MGC Pharmaceuticals Ltd. announced that its MGC Derma division has now officially launched its first Derma Plus product. The product is the Herbal Repair Cream which utilises proprietary cannabidiol (CBD) compounds and is used for the daily relief of mild forms of psoriasis. The psoriasis symptoms successfully treated through the independent tests completed to date include effective reduction of skin irritation (by 69 % after 4 weeks of evaluation), and treatment of skin itchiness, flaking and severe dryness. Independent experts estimate that the global market for psoriasis treatment, which was worth $7.8 billion in 2015, is projected to expand at a compound annual growth rate (CAGR) of 5.10% during the period for 2016 to 2024 and attain a value of $12.1 billion by the end of the forecast period. The Herbal Repair Cream is as of 4 January 2018 available for sale to MGC Derma customers globally through their existing commercial distribution channels and eCommerce platforms, including the MGC Derma website: https://mgcderma.com/cbd-herbal-repair-cream and throughout the European Union, North America and Australasia where the product is approved for sale.